Ahmed Kaid Alantary

Prof. Ahmed Kaid Alantary

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
Elsayed Abdelhadi ElmorsyElsayed Abdelhadi Elmorsy
Elsayed Abdelhadi Elmorsy
MKMostafa M Khodeir
Mostafa M Khodeir
MKManal M. Kamal
Manal M. Kamal
MEMohamed El-Sayed
Mohamed El-Sayed
MAMariam ALHARBI
Mariam ALHARBI
Sameh SaberSameh Saber
Sameh Saber
Renal ischemia is a common cause of acute kidney injury (AKI), particularly in critical care settings, and remains a major challenge in nephrology due to the lack of effective therapeutic options. In AKI, there is an overstimulation of NAD+-consuming enzymes leading to NAD+ depletion. To help replenish cellular NAD+ stores, this study explores for the first time the therapeutic potential of activating nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in the NAD+ salvage pathway, in a rat model of unilateral renal ischemia-reperfusion injury (IRI). Our findings demonstrate that SBI797812 (SBI)-induced NAMPT activation significantly improves renal function post-IRI, primarily through the NAD+/SIRT1/PGC-1α signaling pathway. NAMPT activation resulted in significant improvement in kidney function, including restored urine flow rate, reduced creatinine and blood urea nitrogen (BUN) levels, and decreased kidney injury biomarkers such as KIM-1 and NGAL. Additionally, SBI led to a reduction in inflammatory markers (NFκB, TNF-α and IL-6), oxidative stress markers, and caspase-3, indicating enhanced renal protection. Western blot analysis further revealed upregulation of key mitochondrial biogenesis markers, including SIRT1, PGC-1α, and TFAM, highlighting the link between NAD+ restoration and improved mitochondrial function. In contrast, the inhibition of NAMPT with FK866 exacerbates injury, as indicated by worsened histological features, increased inflammation, and tubular necrosis, confirming the crucial role of NAMPT in mitigating ischemic damage. Considering the importance of NAD metabolism in mitochondrial function and cellular resiliency to tissue injury, these results underscore NAMPT activation as a promising therapeutic strategy for renal IRI, offering new insights for the management of ischemic AKI.

2 May 2026 in Molecules
Verified
Journal Article
Open access
PDF file
AAAhmed N. Al-Hakimi
Ahmed N. Al-Hakimi
SAsadeq Mohammed alhazmy
sadeq Mohammed alhazmy
MAMAHAL IBRAHIM Alhagri
MAHAL IBRAHIM Alhagri
Sabri MessaoudiSabri Messaoudi
Sabri Messaoudi
AAAhmed Kaid Alantary
Ahmed Kaid Alantary
TATahani Meataq Hamad Alresheedi
Tahani Meataq Hamad Alresheedi
This study reports the synthesis and characterization of a novel benzimidazole-derived Schiff base (BIMPB) via the condensation of (1H-benzo[d]imidazol-2-yl)methanamine with 1-phenylbutane-1,3-dione. The structure was confirmed using 1H-NMR, 13C-NMR and FT-IR spectroscopy. Photophysical properties were extensively evaluated, revealing a strong S0 → S2 transition at 212 nm and fluorescence emission peaks at 396 and 410 nm, corresponding to π → π* and n → π* transitions. BIMPB demonstrated significant sensitivity to pH variations, exhibiting blue shifts of 11–23 nm across different environments. Furthermore, the compound acts as a fluorescent chemosensor for Cu2+ and Ca2+ ions, where coordination leads to a substantial reduction in fluorescence intensity accompanied by a distinct blue shift. The interaction between BIMPB and DNA was investigated using UV-Vis and fluorescence titration. The results showed a hypochromic effect and a minor shift in the absorption peak from 342 nm to 340 nm, suggesting a binding mechanism dominated by intercalation or electrostatic interactions. A high binding constant (Kb = 2.1 × 105 M−1) and a fluorescence quenching efficiency of 58.9% confirm the formation of a stable complex. Stern–Volmer analysis indicated a static quenching mechanism. These experimental findings, supported by molecular docking studies (binding energy = −8.3 kcal/mol), highlight the potential of BIMPB as a sensitive molecular probe for DNA-targeting and chemical sensing applications.

27 August 2025 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
Elsayed Abdelhadi ElmorsyElsayed Abdelhadi Elmorsy
Elsayed Abdelhadi Elmorsy
Sameh SaberSameh Saber
Sameh Saber
AAAhmad Alhowail
Ahmad Alhowail
AEAbousree T. Ellethy
Abousree T. Ellethy
EMEnas A. Mohamed
Enas A. Mohamed
MKMostafa M. Khodeir
Mostafa M. Khodeir

Verified
Journal Article
Open access
PDF file
AAAhmed Kaid Alantary
Ahmed Kaid Alantary
SHSara Z. Hamdan
Sara Z. Hamdan
EAEman Adam
Eman Adam
MYMohamad Yosof
Mohamad Yosof
AMAhmed Mohamedain
Ahmed Mohamedain
Hamdan Zaki HamdanHamdan Zaki Hamdan
Hamdan Zaki Hamdan
Pompe disease is a rare autosomal recessive multisystem disorder caused by pathogenic variants in the acid alpha-glucosidase (GAA) gene, resulting in lysosomal glycogen accumulation and a broad clinical spectrum ranging from rapidly fatal infantile-onset disease (IOPD) to slowly progressive late-onset Pompe disease (LOPD). The genetic epidemiology of Pompe disease across the Middle East, North Africa, and Turkey (MENAT) region remains poorly characterized despite high regional rates of consanguinity. We systematically searched PubMed, ScienceDirect, Google Scholar, and Scopus from inception to July 2026 for studies reporting GAA variants in patients with Pompe disease from MENAT countries, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included 24 studies comprising 134 patients with Pompe disease, identifying 61 distinct GAA variants. Twelve variants were unique to the MENAT region. Missense variants were the most common variant type, accounting for 50.8% of all distinct variants, followed by frameshift variants 19.7%. Egypt contributed the largest number of reported patients (24/134, 17.9%) followed by Saudi Arabia, Iran, and Iraq (18/134, 13.4%) for each country. The most prevalent variant across the MENAT region is the leaky intronic splice-site variant c.-32-13T>G, reported in 11.2% of all patients and in cases from Turkey, Algeria, Iran and Egypt. Of the 61 distinct variants, 35 were associated with IOPD and 24 with LOPD, with c.1064T>C (p.Leu355Pro) and c.2104C>T (p.Arg702Cys) reported in association with both phenotypes. This systematic review identified country-specific variants in the MENAT region related to Pompe disease that are distinct from other reported variants worldwide. Further studies with larger sample sizes are needed to comprehend the genotype–phenotype correlation for Pompe disease in the MENAT region.